Andria Rakotomalala

Medicine · Health Sciences

3h-index221citations36works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(33), ATP Synthase and ATPases Research(11), Neuroblastoma Research and Treatments(10), Cancer, Hypoxia, and Metabolism(9), TGF-β signaling in diseases(7)

Publications36 total

Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
2025Open Access
Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
2025Open Access
BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomas
eLife·2024· 3 citedOpen Access
Author response: BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomas
2024Open Access
Supplementary Data from ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma
2024Open Access
Supplementary Data from ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma
2024Open Access
Supplementary Data from ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma
2024Open Access
Supplementary Data from ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma
2024Open Access
Data from ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma
2024Open Access
BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomas
2024Open Access
Author response: BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomas
2024Open Access
Reviewer #2 (Public Review): BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomas
2023Open Access
Author Response: BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomas
2023Open Access
BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomas
2023Open Access
BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomas
eLife·2023· 3 citedOpen Access
EXTH-36. COMBINING ONC201 AND PAXALISIB FOR THE TREATMENT OF DIFFUSE MIDLINE GLIOMA (DMG); THE PRECLINICAL RESULTS UNDERPINNING THE INTERNATIONAL PHASE II CLINICAL TRIAL (NCT05009992)
Neuro-Oncology·2023Open Access
BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomas
2023· 2 citedOpen Access
Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
2023Open Access
Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
2023Open Access
Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
2023Open Access
page 1 of 2Next →

Frequent Co-authors

Samuel Meignan(36), Eddy Pasquier(34), Marion Le Grand(31), Evangeline R. Jackson(22), Ryan J. Duchatel(22), Dilana E. Staudt(22), Mika L. Persson(22), Abdul Mannan(22), Sridevi Yadavilli(22), Sarah Parackal(22), Shaye Game(22), Wai Chin Chong(22), Padraic S. Kearney(22), Alicia M. Douglas(22), Izac J. Findlay(22), Zacary P. Germon(22), David A. Skerrett‐Byrne(22), Brett Nixon(22), Nathan D. Smith(22), Bryan W. Day(22)